48,790
edits
Line 938: | Line 938: | ||
===IHC=== | ===IHC=== | ||
*HER2/neu +ve (strong).<ref name=pmid17142577>{{Cite journal | last1 = Iczkowski | first1 = KA. | last2 = Montironi | first2 = R. | title = Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu. | journal = J Clin Pathol | volume = 59 | issue = 12 | pages = 1327-30 | month = Dec | year = 2006 | doi = 10.1136/jcp.2005.035147 | PMID = 17142577 }}</ref> | *HER2/neu +ve (strong).<ref name=pmid17142577>{{Cite journal | last1 = Iczkowski | first1 = KA. | last2 = Montironi | first2 = R. | title = Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu. | journal = J Clin Pathol | volume = 59 | issue = 12 | pages = 1327-30 | month = Dec | year = 2006 | doi = 10.1136/jcp.2005.035147 | PMID = 17142577 }}</ref> | ||
=Metastatic tumour= | |||
==Urothelial carcinoma== | |||
===General=== | |||
*Spreads from the bladder usually - common.<ref name=pmid22520044>{{Cite journal | last1 = Huguet | first1 = J. | title = [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice]. | journal = Actas Urol Esp | volume = 36 | issue = 9 | pages = 545-53 | month = Oct | year = 2012 | doi = 10.1016/j.acuro.2012.02.005 | PMID = 22520044 }}</ref> | |||
*Identified by endoscopic loop biopsy.<ref name=pmid17338657>{{Cite journal | last1 = Liedberg | first1 = F. | last2 = Chebil | first2 = G. | last3 = Månsson | first3 = W. | title = Urothelial carcinoma in the prostatic urethra and prostate: current controversies. | journal = Expert Rev Anticancer Ther | volume = 7 | issue = 3 | pages = 383-90 | month = Mar | year = 2007 | doi = 10.1586/14737140.7.3.383 | PMID = 17338657 }}</ref> | |||
Treatment:<ref name=pmid17338657/> | |||
*Cytoprostatectomy - stromal invasion ''or'' extensive intraductal involvement. | |||
*Endoscopic resection and BCG - limited extent without stromal invasion. | |||
===Microscopic=== | |||
Features: | |||
*Divided into: | |||
*#Stromal invasion. | |||
*#Without stromal invasion. | |||
Notes: | |||
*Stromal involvement common ~ 75% of cases.<ref name=pmid23250619>{{Cite journal | last1 = Ichihara | first1 = K. | last2 = Masumori | first2 = N. | last3 = Kitamura | first3 = H. | last4 = Hasegawa | first4 = T. | last5 = Tsukamoto | first5 = T. | title = Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens. | journal = Int J Clin Oncol | volume = | issue = | pages = | month = Dec | year = 2012 | doi = 10.1007/s10147-012-0508-3 | PMID = 23250619 }}</ref> | |||
=See also= | =See also= |
edits